FundingWatcher
Home / Investors / Biotech investors / Biotech investors in DACH

Biotech investors in DACH

Updated 16 Nov 2026

Reset

Venture funds

5 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 HTGF (High-Tech Gruenderfonds)
HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate.
Bonn, Germany
Biotech, Health care Seed, Early stage venture, Late stage venture 28% 5
2 BlueYard Capital
BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio.
Berlin, Germany
Fintech, Biotech Seed, Early stage venture 41% 3
3 Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix.
Ingelheim Am Rhein, Germany
Biotech, Health care Seed, Early stage venture 47% 3
4 Nextech Invest
Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio.
Zürich, Switzerland
Health care, Biotech Early stage venture, Late stage venture 31% 2
5 Nucleus Capital
Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia.
Berlin, Germany
Biotech, Health care Seed, Early stage venture 32% 2

Table 1. Biotech investors in DACH: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in DACH
One-time CSV
  • 97 firms, 96 with a website
  • 75 firm email addresses
  • 60 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-dach.csv97 rows × 15 columns
InvestorTypeLocationEmailPhone
HTGF (High-Tech Gruenderfonds)Venture capital firmBonn, Germany•••@htgf.de+49 22•••
Venture KickStartup incubatorSchlieren, Switzerland•••@venturekick.ch+41 (2•••
KfWGovernment investment officeFrankfurt, Germany•••@kfw.de49 69 •••
Novartis Venture FundCorporate venture armBasel, Switzerland•••@sosei.com877 28•••
Bayern KapitalVenture capital firmLandshut, Germany•••@bayernkapital.de+49871•••
BioMedPartnersVenture capital firmBasel, Switzerland•••@biomedvc.com+41 61•••
Foundation for Innovation and Technology (FIT)Entrepreneurship programLausanne, Switzerland•••@fondation-fit.ch+41 21•••
Verve VenturesVenture capital firmZug, Switzerland•••@verve.vc

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

97
Investors
75
With email
60
With phone
58
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in DACH

30 of 97, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany Biotech, Health care Rabot Energy, CereGate, syte 17 1,026 290 136 •••@htgf.de +49 22••• In the CSV
2 Venture Kick Startup incubator Schlieren, Switzerland Health care, Biotech UniSieve, Cotierra, Jaipur Robotics 13 1,459 1,342 82 •••@venturekick.ch +41 (2••• In the CSV
3 KfW Government investment office, Investment bank Frankfurt, Germany Biotech, Health care CryoTherapeutics, Vectoflow, HelloDuty 198 29 56 •••@kfw.de 49 69 ••• In the CSV
4 Novartis Venture Fund Corporate venture arm, Venture capital firm Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
5 Bayern Kapital Venture capital firm Landshut, Germany Health care, Artificial intelligence mbiomics, SPiNE, Driveblocks 4 294 41 41 •••@bayernkapital.de +49871••• In the CSV
6 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany Biotech, Health care smartbax, xCures, Tacalyx 4 99 47 12 +49 61•••
7 BioMedPartners Venture capital firm Basel, Switzerland Biotech, Health care TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics 87 29 22 •••@biomedvc.com +41 61••• In the CSV
8 Foundation for Innovation and Technology (FIT) Entrepreneurship program, Government investment office Lausanne, Switzerland Health care, Biotech Adaptyv Biosystems, Carewell, Alithea Genomics 7 345 329 35 •••@fondation-fit.ch +41 21••• In the CSV
9 Verve Ventures Venture capital firm Zug, Switzerland Health care, Artificial intelligence Stake, Nuclera 2 275 37 35 •••@verve.vc In the CSV
10 Innosuisse Government investment office Berne, Switzerland Health care, Biotech UniSieve, KEMARO AG, Seprify 6 232 184 13 •••@innosuisse.ch +41 58••• In the CSV
11 Wellington Partners Venture capital firm Munich, Germany Health care, Biotech nyra health 1 252 80 65 •••@wellington-partners.com +44 20••• In the CSV
12 MassChallenge Switzerland Startup accelerator Renens, Switzerland Biotech, Artificial intelligence Treeless, Perovskia, SolidWatts 5 227 219 2 In the CSV
13 NRW.BANK Government investment office, Investment bank Düsseldorf, Germany Artificial intelligence, Biotech Lumoview Building Analytics, Elixion Medical, Alteva 126 28 17 •••@nrwbank.de +32 2 ••• In the CSV
14 VI Partners Venture capital firm Altendorf, Switzerland Health care, Biotech L.E.S.S. 1 111 26 22 •••@vipartners.ch +41 41••• In the CSV
15 MIG Capital Venture capital firm Munich, Germany Biotech, Health care NavVis, mbiomics 2 95 43 15 •••@mig.ag In the CSV
16 Leaps by Bayer Corporate venture arm Leverkusen, Germany Health care, Biotech 9amHealth, CORXEL Pharmaceuticals 2 113 45 13 In the CSV
17 BlueYard Capital Venture capital firm Berlin, Germany Fintech, Biotech Zafrens, Castelion, Transcripta Bio 7 102 42 4 +49 61••• In the CSV
18 German Federal Ministry of Research, Technology and Space Government investment office Bonn, Germany Biotech, Health care eClear, NVision Quantum Technologies 2 62 39 13 •••@bmftr.bund.de +49 (0••• In the CSV
19 APEX Ventures Venture capital firm Vienna, Austria Health care, Artificial intelligence OKAPI:Orbits, Quibim, Lyfegen 58 17 2 •••@apex.ventures (516) ••• In the CSV
20 Fraunhofer Venture Venture capital firm Munich, Germany Biotech, Health care Cellbox Solutions 1 40 6 5 •••@fraunhoferventure.de +49 89••• In the CSV
21 Pureos Bioventures Venture capital firm Küsnacht, Switzerland Biotech, Health care NovaGo Therapeutics 1 35 13 6 In the CSV
22 HBM Healthcare Investments Venture capital firm Zug, Switzerland Biotech, Health care 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics 260 47 90 •••@hbmhealthcare.com +41 41•••
23 redalpine Venture capital firm Zürich, Switzerland Artificial intelligence, Fintech Basecamp Research, Albatross AI 2 188 69 22 •••@redalpine.com +41 44••• In the CSV
24 Possible Ventures Venture capital firm Munich, Germany Hardware, Artificial intelligence Antaris, Arlula, InSpacePropulsion Technologies 4 152 9 9 In the CSV
25 IFB Innovationsstarter Venture capital firm Hamburg, Germany Health care, Biotech recalm, apoQlar, SupplyET 88 35 6 +49 40••• In the CSV
26 LBBW VC Corporate venture arm Stuttgart, Germany Biotech, Health care Exciva 1 47 14 7 +49 71••• In the CSV
27 Nucleus Capital Venture capital firm Berlin, Germany Biotech, Health care Apoha, Biomia 2 44 14 2 In the CSV
28 Amino Collective Venture capital firm Berlin, Germany Health care, Biotech Tandem Health, Rivia, Biomia 3 42 2 2 •••@aminocollective.com In the CSV
29 EMBL Ventures Venture capital firm Heidelberg, Germany Biotech, Health care Luxendo, Allecra Therapeutics, ImevaX 20 5 6 •••@embl-ventures.com +49 (6••• In the CSV
30 b.value AG Venture capital firm Dortmund, Germany Biotech, Health care Cellbricks Therapeutics 1 13 3 0 •••@b-value.de +49 (0••• In the CSV

Table 2. Biotech investors in DACH: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 97.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 HTGF (High-Tech Gruenderfonds) Bonn, Germany 17 257 Rabot Energy, CereGate, syte
2 Venture Kick Schlieren, Switzerland 13 129 UniSieve, Cotierra, Jaipur Robotics
3 Picus Capital Munich, Germany 8 69 Reflex, Baselayer, FINN
4 BlueYard Capital Berlin, Germany 7 25 Zafrens, Castelion, Transcripta Bio
5 Earlybird Venture Capital Berlin, Germany 7 72 finmid, ColibrITD, Quantum Diamonds
6 Foundation for Innovation and Technology (FIT) Lausanne, Switzerland 7 30 Adaptyv Biosystems, Carewell, Alithea Genomics
7 Cherry Ventures Berlin, Germany 7 58 Moss, Stenon, bunch
8 Innosuisse Berne, Switzerland 6 29 UniSieve, KEMARO AG, Seprify
9 Speedinvest Vienna, Austria 6 136 hexafarms, Nomos, Greyparrot
10 Leblon Capital Munich, Germany 5 38 Mural, Rivio, Taktile
11 HV Capital Munich, Germany 5 72 Rabot Energy, FINN, NEURA Robotics
12 MassChallenge Switzerland Renens, Switzerland 5 35 Treeless, Perovskia, SolidWatts
13 Founderful Zürich, Switzerland 4 21 UniSieve, Adaptyv Biosystems, Zuriq
14 TGFS - Technologiegründerfonds Sachsen Leipzig, Germany 4 22 Prodlane, BirdsView, Peeriot
15 Boehringer Ingelheim Venture Fund Ingelheim Am Rhein, Germany 4 14 smartbax, xCures, Tacalyx

Table 3. Biotech investors in DACH: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego, United States Series A $6.0M 2026-11-03 $35.0M BlueYard Capital 11 to 50 2022
Reflex Reflex is an open-source Python framework for building and deploying web applications. Software San Francisco, United States Series A $14.0M 2026-10-29 $19.5M Picus Capital 11 to 50 2023
Mural Mural offers a financial platform for cross-border payments, fund transfers, and digital asset transactions. Fintech New York, United States Series A $15.0M 2026-10-20 $20.6M Leblon Capital 11 to 50 2022
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M Fraunhofer Venture 11 to 50 2017
Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence San Francisco, United States Series A $12.0M 2026-10-15 $22.9M Calm/Storm VC 11 to 50 2018
Rabot Energy Rabot Energy supplies green electricity with flexible and smart tariffs for homes and electric vehicles. Energy Hamburg, Germany Series B $56.1M 2026-10-14 $79.7M HV Capital, HTGF (High-Tech Gruenderfonds) 101 to 250 2021
UniSieve UniSieve provides molecular separation membrane solutions for cleantech applications. Energy Zürich, Switzerland Series A $9.0M 2026-10-08 $19.7M Venture Kick, Founderful, Innosuisse 11 to 50 2018
finmid finmid provides embedded lending infrastructure that powers platform growth. Fintech Berlin, Germany Series A $19.1M 2026-10-06 $58.0M Earlybird Venture Capital 11 to 50 2021
hexafarms Hexafarms develops AI-powered software and hardware for commercial greenhouse and protected-crop operations. Software Berlin, Germany Seed $5.4M 2026-10-06 $7.8M Speedinvest 11 to 50 2021
Procuros Procuros is a fintech company that automates manual B2B transactions into transparent flows. Fintech Hamburg, Germany Series A $22.3M 2026-10-05 $32.5M SquareOne Venture Capital 11 to 50 2021

Table 4. Biotech investors in DACH: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 1,151 66%
Health care 404 23%
Artificial intelligence 368 21%
Biotech 330 19%
Hardware 240 14%
Fintech 235 14%
Commerce 137 8%
Education 61 4%
Energy 60 3%
Cybersecurity 46 3%

Table 5. Biotech investors in DACH: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in DACH by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
Germany 60 62%
Switzerland 32 33%
Austria 5 5%

Table 7. Biotech investors in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Munich 14 14%
Berlin 13 13%
Zürich 9 9%
Basel 5 5%
Geneva 5 5%
Vienna 4 4%
Zug 3 3%
Stuttgart 3 3%
Bonn 2 2%
Frankfurt 2 2%
Lausanne 2 2%
Hamburg 2 2%

Table 8. Biotech investors in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 6 7%
2010s 31 34%
2000s 32 35%
1990s 16 17%
1980s 1 1%
1970s 2 2%

Table 9. Biotech investors in DACH by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in DACH are on the list?
97, in the file dated 16 November 2026. 58 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
75 of the 97 carry an email address in the download and 60 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 97 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 97 rows, 75 firm email addresses and 60 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 59 of the 75 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in DACH: 97 rows, CSV, $29 one-time.

At once: the CSV with 97 rows, 75 firm email addresses and 60 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 59 of the 75 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in DACH

Other portfolio sectors in DACH

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 97 biotech investors in DACH, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/dach/